Cancer · 1990 · 83 citations · 19 references
MedicineOncologyPathologyCytogeneticsCytopathologyNeoplasiaCancer CytogeneticsCirculating Tumor Dna AnalysisJoint PathologyMalignant NeoplasmsTumor ClassificationTumor CytopathologyClinical Outcome MeasurementClinicopathologic FeaturesDna Content MeasurementFlow Cytometric AnalysisJoint TumorsMitotic Count EvaluationSarcoma ClassificationSarcoma Pathology
The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P less than 0.001), tumor size (P less than 0.001), and ploidy status (P less than 0.003) correlated significantly with patient survival. A marginally significant correlation between mitotic count and patient survival was also observed (P = 0.04). Histologic subtypes (monophasic versus biphasic), mitotic count, and S-phase by flow cytometry had no significant influence on the clinical outcome of patients with synovial sarcoma in this study. The authors conclude that DNA ploidy analysis is a significant objective probe in the prognostication of patients with synovial sarcoma.
19
Cellular DNA content as a marker of neoplasia in man
Barthel Barlogie, Benjamin Drewinko, J. Schumann et al. · The American Journal of Medicine · 1980 · 300 citations
Tendosynovial sarcoma.A clinicopathological study of 136 Cases
Steven I. Hajdu, Man H. Shiu, Joseph G. Fortner · Cancer · 1977 · 238 citations
P H Wright, F H Sim, E H Soule et al. · Journal of Bone and Joint Surgery · 1982 · 143 citations